경구 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제제별, 유형별, 치료 분야별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

The Global Oral Drug Delivery Market, valued at USD 129.77 Billion in 2024, is projected to experience a CAGR of 7.80% to reach USD 203.65 Billion by 2030. The Global Oral Drug Delivery Market encompasses the segment of the pharmaceutical industry dedicated to developing, manufacturing, and commercializing therapeutic agents administered via the oral route. This method is highly favored due to its inherent patient convenience, ease of administration, and potential for improved compliance compared to other delivery methods. Key drivers propelling this market include the increasing global prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer, which necessitate long-term medication regimens.

Key Market Drivers

Technological advancements in drug delivery systems and expanded investment in pharmaceutical research and development exert considerable influence on the Global Oral Drug Delivery Market. Innovations in solubility enhancement, controlled release mechanisms, and targeted delivery are broadening the range of orally administered therapies, including complex molecules once limited to injectable routes. These developments improve drug stability, bioavailability, and therapeutic precision. For instance, according to Fierce Biotech, in April 2025, Roche acquired Carmot Therapeutics for $2.7 billion in late 2023, securing access to three GLP-1 receptor agonists with potential for treating obesity, including oral administration. Such strategic investments emphasize the industry's dedication to patient-friendly oral formulations.

Key Market Challenges

A significant challenge impeding market expansion for oral drug delivery is the stringent regulatory approval processes. These complex procedures inherently increase the time and financial investment required to bring new oral formulations to market. This extended development timeline and heightened cost create substantial barriers for pharmaceutical companies, particularly those developing innovative therapies, by prolonging the period before potential revenue generation.

Key Market Trends

The development of personalized oral therapies is a significant trend reshaping the Global Oral Drug Delivery Market by moving towards treatments tailored to individual patient profiles. This approach leverages advancements in diagnostics and genomics to customize drug selection, dosage, and formulation, enhancing therapeutic efficacy and minimizing adverse effects. According to the Personalized Medicine Coalition (PMC), in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities. These approvals underscore a growing industry commitment to individualized treatment pathways.

Key Market Players

• Novartis AG
• Biocon Ltd.
• NovoNordisk A/S
• F.Hoffmann-La Roche Ltd.
• Bayer AG
• Emishphere Technologies Inc.
• Enteris Biopharma Inc.
• Merrion Pharmaceuticals Plc.
• Amgen Inc.
• Pfizer Inc.

Report Scope:

In this report, the Global Oral Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Drug Delivery Market, By Formulation:

• Tablets
• Capsules
• Drops
• Liquid or Syrup

Oral Drug Delivery Market, By Type:

• Controlled Release
• Orodispersible Tablets
• Others

Oral Drug Delivery Market, By Therapy Area:

• Oncology
• Musculoskeletal
• Immunology
• Gastrointestinal
• Respiratory
• Cardiovascular
• Others

Oral Drug Delivery Market, By End User:

• Hospitals
• Ambulatory Surgical Centres
• Diagnostic Centres
• Clinics
• Others

Oral Drug Delivery Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Drug Delivery Market.

Available Customizations:

Global Oral Drug Delivery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Drug Delivery Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)
  • 5.2.2. By Type (Controlled Release, Orodispersible Tablets, Others)
  • 5.2.3. By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others)
  • 5.2.4. By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Oral Drug Delivery Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Formulation
  • 6.2.2. By Type
  • 6.2.3. By Therapy Area
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oral Drug Delivery Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Formulation
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Therapy Area
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Oral Drug Delivery Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Formulation
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Therapy Area
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Oral Drug Delivery Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Formulation
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Therapy Area
      • 6.3.3.2.4. By End User

7. Europe Oral Drug Delivery Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Formulation
  • 7.2.2. By Type
  • 7.2.3. By Therapy Area
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oral Drug Delivery Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Formulation
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Therapy Area
      • 7.3.1.2.4. By End User
  • 7.3.2. France Oral Drug Delivery Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Formulation
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Therapy Area
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Oral Drug Delivery Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Formulation
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Therapy Area
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Oral Drug Delivery Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Formulation
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Therapy Area
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Oral Drug Delivery Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Formulation
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Therapy Area
      • 7.3.5.2.4. By End User

8. Asia Pacific Oral Drug Delivery Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Formulation
  • 8.2.2. By Type
  • 8.2.3. By Therapy Area
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Oral Drug Delivery Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Formulation
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Therapy Area
      • 8.3.1.2.4. By End User
  • 8.3.2. India Oral Drug Delivery Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Formulation
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Therapy Area
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Oral Drug Delivery Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Formulation
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Therapy Area
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Oral Drug Delivery Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Formulation
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Therapy Area
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Oral Drug Delivery Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Formulation
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Therapy Area
      • 8.3.5.2.4. By End User

9. Middle East & Africa Oral Drug Delivery Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Formulation
  • 9.2.2. By Type
  • 9.2.3. By Therapy Area
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Oral Drug Delivery Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Formulation
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Therapy Area
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Oral Drug Delivery Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Formulation
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Therapy Area
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Oral Drug Delivery Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Formulation
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Therapy Area
      • 9.3.3.2.4. By End User

10. South America Oral Drug Delivery Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Formulation
  • 10.2.2. By Type
  • 10.2.3. By Therapy Area
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Oral Drug Delivery Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Formulation
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Therapy Area
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Oral Drug Delivery Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Formulation
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Therapy Area
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Oral Drug Delivery Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Formulation
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Therapy Area
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Oral Drug Delivery Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novartis AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Biocon Ltd.
• 15.3. NovoNordisk A/S
• 15.4. F.Hoffmann-La Roche Ltd.
• 15.5. Bayer AG
• 15.6. Emishphere Technologies Inc.
• 15.7. Enteris Biopharma Inc.
• 15.8. Merrion Pharmaceuticals Plc.
• 15.9. Amgen Inc.
• 15.10. Pfizer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer